Investors

Discover Virbac's Statement on extra-financial performance

SALES 2019
938 M
59%
Companion
animals
41%
Food
producing
animals

(in € million)

Financial public release
& News

2020 half year results

2020/09/16 - Financial public releases

Operating profit from ordinary activities up sharply for the first half of 2020 reflecting revenue resiliency and strong expenditure restraint during the Covid-19 crisis

Read more

2020 second quarter consolidated sales

2020/07/20 - Financial public releases

Revenue grew by +5.0% at constant exchange rates in the first half of 2020 (+4.5% excluding Sentinel), impacted by a decline in the second quarter of the year

Read more

Divestment of US rights

2020/07/02 - Financial public releases

Virbac completes divestment of U.S. Rights to SENTINEL® brands to MSD Animal Health

Read more

Events
Wednesday October 14

2020 third quarter sales

2020/10/14 

Read moreRead less

Wednesday October 14, 2020 after market close

2020 third quarter sales
(quiet period from September 30, 2020)

Tuesday January 19

2020 fourth quarter year sales

2021/01/19 

Read moreRead less

Thursday January 16, 2021 after market close

2020 fourth quarter year sales
(quiet period from January 5, 2021)

Past Events
Wednesday September 16

2020 interim result

2020/09/16 

Read moreRead less

Wednesday September 16, 2020 after market close

2020 interim result
(quiet period from August 19, 2020)

Monday July 20

2020 second quarter sales

2020/07/20 

Read moreRead less

Monday July 20, 2020 after market close

2020 second quarter sales
(quiet period from July 6, 2020)

Monday June 22

Annual sharehorders' meeting

2020/06/22 

Read moreRead less

Monday June 22, 2020

Annual sharehorders' meeting